Immunology News and Research

Latest Immunology News and Research

Gene behind Vel blood group discovered

Researchers have uncovered the gene at the root of a human blood group that has remained a mystery for the past 60 years. They showed that a genetic deletion on this gene is responsible for the lack of this blood group in some people.

8 Apr 2013

Phase 3 study results of simeprevir in hepatitis C patients to be presented at EASL Congress

Janssen R&D Ireland announces that data will be presented on the investigational protease inhibitor simeprevir (TMC435) for the treatment of hepatitis C at The International Liver Congress 2013 of the European Association for the Study of the Liver, which will take place April 24 to 28 in Amsterdam, The Netherlands.

8 Apr 2013

Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

Nektar Therapeutics today presented positive preclinical data for NKTR-214, a novel cancer immunotherapy which targets the IL-2 receptor complex, at the 2013 American Association for Cancer Research Annual Meeting.

8 Apr 2013

Dual-signaling CAR T cells show potent anti-cancer activity in animal model

The need to distinguish between normal cells and tumor cells is a feature that has been long sought for most types of cancer drugs.

8 Apr 2013

New two-step immunotherapy approach offers new hope for ovarian cancer patients

As many as three quarters of advanced ovarian cancer patients appeared to respond to a new two-step immunotherapy approach -- including one patient who achieved complete remission -- according research from the Perelman School of Medicine at the University of Pennsylvania that will be presented today in a press conference at the AACR Annual Meeting 2013 (Presentation #LB-335).

8 Apr 2013

National Jewish Health researchers unravel mystery of adjuvants

Aluminum salts, or alum, have been injected into billions of people as an adjuvant to make vaccines more effective.

8 Apr 2013

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gy-rgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer.

7 Apr 2013

Nobel Prize recipient describes on innate immunity at Annual Drosophila Research Conference

A young scientist's astute observation - that grasshoppers don't get sick - eventually led to profound insights into our own immunity.

6 Apr 2013

Research examines stress, space flight impact on body's ability to fight viruses

Fighting viruses is a regular battle for your body, one it routinely wins if it has a healthy immune system. But compromised systems, as experienced occasionally by astronauts during space flights, can allow viruses to return.

6 Apr 2013

MyAllergyTest kit allows allergy sufferers to test themselves against 10 key allergens

According to the American College of Allergy, Asthma and Immunology, more than 60 million Americans suffer from allergies. However, most people don't get tested for allergies, so they often do not know for certain what causes their allergies.

6 Apr 2013

Research: Hepatitis A virus steals membranes from infected cells to protect it from antibodies

Viruses have historically been classified into one of two types - those with an outer lipid-containing envelope and those without an envelope.

5 Apr 2013

People to participate in Rally for Medical Research to raise awareness of NIH funding

On April 8 at 11 a.m., thousands of people will gather on the Carnegie Library grounds to participate in the Rally for Medical Research to raise awareness of the critical need to make funding for the National Institutes of Health a priority.

5 Apr 2013

Observation of antibody evolution in HIV-1 patient provides insights into vaccine development

Observing the evolution of a particular type of antibody in an infected HIV-1 patient, a study spearheaded by Duke University, including analysis from Los Alamos National Laboratory, has provided insights that will enable vaccination strategies that mimic the actual antibody development within the body.

5 Apr 2013

Dermatology researcher secures federal grant to explore psoriasis

A dermatology researcher at Case Western Reserve University School of Medicine has secured a five-year, $1.9 million federal grant to explore whether a specific molecule may play a pivotal role in the development and progression of psoriasis.

5 Apr 2013

Same factor that helps fight off severe inflammatory ailments also functions as enemy

The same factor in our immune system that is instrumental in enabling us to fight off severe and dangerous inflammatory ailments is also a player in doing the opposite at a later stage, causing the suppression of our immune response.

4 Apr 2013

Finding solutions to protect U.S. troops against invisible killers

A Saint Louis University researcher has received a contract worth up to $980,000 to see if two cancer medications have the potential of protecting U.S. troops from biological agents that could be unleashed during an attack.

4 Apr 2013

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

ERYTECH Pharma SA announced today that it has received clearance of its Investigational New Drug Application from the United States Food and Drug Administration to initiate a Phase I clinical trial of its product ERYASP, L-asparaginase loaded erythrocytes, in patients 40 years or older with newly diagnosed Acute Lymphoblastic Leukemia.

4 Apr 2013

Doctors give new hope for leukemia patients

Leukemia patients receive a bone marrow transplant, which allows them to build a "new" immune system. However, this immune system not only attacks cancer cells but healthy tissue too.

3 Apr 2013

LSUHSC researchers study common STI

Research led by David H. Martin, MD, Professor and Chief of Infectious Diseases at LSU Health Sciences Center New Orleans, has found that a common sexually transmitted infection-causing parasite "cultivates" bacteria beneficial to it, changing thinking about which comes first-infection or bacteria.

3 Apr 2013

Antibodies neutralize mosquito-transmitted chikungunya virus, researchers reveal

Researchers have learned the precise structure of the mosquito-transmitted chikungunya virus pathogen while it is bound to antibodies, showing how the infection is likely neutralized.

3 Apr 2013

Immunology News and Research

Latest Immunology News and Research

Gene behind Vel blood group discovered

Phase 3 study results of simeprevir in hepatitis C patients to be presented at EASL Congress

Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

Dual-signaling CAR T cells show potent anti-cancer activity in animal model

New two-step immunotherapy approach offers new hope for ovarian cancer patients

National Jewish Health researchers unravel mystery of adjuvants

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Nobel Prize recipient describes on innate immunity at Annual Drosophila Research Conference

Research examines stress, space flight impact on body's ability to fight viruses

MyAllergyTest kit allows allergy sufferers to test themselves against 10 key allergens

Research: Hepatitis A virus steals membranes from infected cells to protect it from antibodies

People to participate in Rally for Medical Research to raise awareness of NIH funding

Observation of antibody evolution in HIV-1 patient provides insights into vaccine development

Dermatology researcher secures federal grant to explore psoriasis

Same factor that helps fight off severe inflammatory ailments also functions as enemy

Finding solutions to protect U.S. troops against invisible killers

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

Doctors give new hope for leukemia patients

LSUHSC researchers study common STI

Antibodies neutralize mosquito-transmitted chikungunya virus, researchers reveal

Industry focus eBook - Immunology (2nd edition) eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring